Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2 immunogenicity at the crossroads.
Allergy. 2020 07; 75(7):1822-1824.A

Authors+Show Affiliations

Division Haematology/Transfusion Medicine, Paul-Ehrlich-Institut, Langen, Germany.Host-Pathogen Interactions, Paul-Ehrlich-Institut, Langen, Germany. Sanford Burnham Prebys Medical Discovery Institute, Immunity and Pathogenesis Program, La Jolla, CA, USA.

Pub Type(s)

Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32401346

Citation

Karamloo, Fariba, and Renate König. "SARS-CoV-2 Immunogenicity at the Crossroads." Allergy, vol. 75, no. 7, 2020, pp. 1822-1824.
Karamloo F, König R. SARS-CoV-2 immunogenicity at the crossroads. Allergy. 2020;75(7):1822-1824.
Karamloo, F., & König, R. (2020). SARS-CoV-2 immunogenicity at the crossroads. Allergy, 75(7), 1822-1824. https://doi.org/10.1111/all.14360
Karamloo F, König R. SARS-CoV-2 Immunogenicity at the Crossroads. Allergy. 2020;75(7):1822-1824. PubMed PMID: 32401346.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2 immunogenicity at the crossroads. AU - Karamloo,Fariba, AU - König,Renate, Y1 - 2020/05/25/ PY - 2020/04/22/received PY - 2020/05/02/revised PY - 2020/05/05/accepted PY - 2020/5/14/pubmed PY - 2020/8/4/medline PY - 2020/5/14/entrez KW - infections KW - inflammation KW - lung diseases other than asthma and COPD KW - vaccines KW - virus SP - 1822 EP - 1824 JF - Allergy JO - Allergy VL - 75 IS - 7 SN - 1398-9995 UR - https://www.unboundmedicine.com/medline/citation/32401346/SARS_CoV_2_immunogenicity_at_the_crossroads_ L2 - https://doi.org/10.1111/all.14360 DB - PRIME DP - Unbound Medicine ER -